Mitochondrial Dysfunction and Targeted Drugs: A Focus on Diabetes

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|20|1986-2001

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.20, 2011-07, pp. : 1986-2001

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxidative Stress and Mitochondrial Dysfunction in Type 2 Diabetes

By  

Current Pharmaceutical Design, Vol. 17, Iss. 36, 2011-12 ,pp. : 3947-3958

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetes

By  

Current Pharmaceutical Design, Vol. 22, Iss. 18, 2016-05 ,pp. : 2640-2649

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative Stress and Mitochondrial Dysfunction in Sepsis: A Potential Therapy with Mitochondria-Targeted Antioxidants

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 4, 2009-08 ,pp. : 376-389

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative Stress and Mitochondrial Dysfunction in Atherosclerosis: Mitochondria-Targeted Antioxidants as Potential Therapy

By  

Current Medicinal Chemistry, Vol. 16, Iss. 35, 2009-12 ,pp. : 4654-4667

Bentham Science Publishers

Access to resources Recommend Favorite

VDAC-Targeted Drugs Affecting Cytoprotection and Mitochondrial Physiology in Cerebrovascular and Cardiovascular Diseases

By  

Current Medicinal Chemistry, Vol. 24, Iss. 40, 2018-01 ,pp. : 4419-4434

Bentham Science Publishers

Access to resources Recommend Favorite